Respiratory syncytial virus mRNA vaccine(Sinovac Life Sciences)

呼吸道合胞病毒mRNA疫苗（北京科兴中维生物）

Report date: 2026/03/09 20:02:04

Base Information

Drug NameRespiratory syncytial virus mRNA vaccine(Sinovac Life Sciences)
Drug Alias Name冻干呼吸道合胞病毒（RSV）mRNA疫苗
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Biological material > Viral vaccineVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsRespiratory Syncytial Virus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesSinovac Life Sciences Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSinovac Biotech Co LtdSinovac Life Sciences Co Ltd
Inactive CompaniesN/A
Active IndicationsRespiratory Syncytial Virus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A